cordycepin has been researched along with Cancer of Stomach in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Gao, M; Lyu, Y; Piao, Y; Ren, X; Wang, Y; Yang, C; Zhang, X; Zhou, X | 1 |
Cho, H; Choi, SJ; Huh, S; Kang, BW; Kang, H; Kim, JG; Lee, S; Ryu, E; Shin, YS | 1 |
An, RB; Chen, LY; Li, ZH; Lin, ZH; Liu, TS; Lv, Y; Piao, YS; Ren, XS; Wang, Y; Yan, WD | 1 |
Du, L; Du, Y; Feng, WH; Tang, J; Yu, J | 1 |
Li, J; Li, X; Liu, B; Masood, M; Nasser, MI; Wei, W; Zhou, Y | 1 |
5 other study(ies) available for cordycepin and Cancer of Stomach
Article | Year |
---|---|
[Cordycepin inhibits the proliferation and migration of human gastric cancer cells by suppressing lipid metabolism via AMPK and MAPK activation].
Topics: AMP-Activated Protein Kinases; Apoptosis; Cadherins; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Deoxyadenosines; Humans; Lipid Metabolism; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; p38 Mitogen-Activated Protein Kinases; Poly(ADP-ribose) Polymerase Inhibitors; Stomach Neoplasms; Vimentin | 2022 |
Adenosine Induces EBV Lytic Reactivation through ADORA1 in EBV-Associated Gastric Carcinoma.
Topics: Adenosine; Animals; Cell Line, Tumor; Deoxyadenosines; Epstein-Barr Virus Infections; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; Herpesvirus 4, Human; Host-Pathogen Interactions; Humans; Mice; Receptor, Adenosine A1; Stomach Neoplasms; Trans-Activators; Up-Regulation; Virus Activation; Xenograft Model Antitumor Assays | 2019 |
Cordycepin suppresses cell proliferation and migration by targeting CLEC2 in human gastric cancer cells via Akt signaling pathway.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Deoxyadenosines; Dose-Response Relationship, Drug; Humans; Lectins, C-Type; Proto-Oncogene Proteins c-akt; Signal Transduction; Stomach Neoplasms | 2019 |
Cordycepin enhances Epstein-Barr virus lytic infection and Epstein-Barr virus-positive tumor treatment efficacy by doxorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; CCAAT-Enhancer-Binding Protein-beta; Cell Line, Tumor; Deoxyadenosines; Dose-Response Relationship, Drug; Doxorubicin; Herpesvirus 4, Human; Humans; Mice, SCID; Oncolytic Virotherapy; Oncolytic Viruses; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C; RNA Interference; Signal Transduction; Stomach Neoplasms; Time Factors; Transfection; Tumor Burden; Virus Activation; Xenograft Model Antitumor Assays | 2016 |
Cordycepin induces apoptosis in SGC‑7901 cells through mitochondrial extrinsic phosphorylation of PI3K/Akt by generating ROS.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxyadenosines; Humans; Membrane Potential, Mitochondrial; Mitochondria; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Receptors, Tumor Necrosis Factor, Member 25; S Phase Cell Cycle Checkpoints; Signal Transduction; Stomach Neoplasms | 2017 |